The CDP application process is closed.
The Leukemia & Lymphoma Society's (LLS) Career Development Program (CDP) provides stipends so that you can devote yourself to researching questions of direct relevance to hematological malignancies and/or relevant pre-malignant conditions.
LLS offers career development awards to postdoctoral fellows as well as early career, independent investigators. Please verify in our guidelines and instructions which award is appropriate for your level of experience and apply to that category of award.
The funding level for Scholars in Clinical Research is increased. The funding level for Fellows and Special Fellows was increased in the prior cycle.
How to Apply/Deadlines
- This year the Career Development application will be completed in 3 phases. See guidelines and instructions for full details.
- Full Application
- LLS uses its own Research Portal powered by Fluxx for preliminary and full application submission. Contact email@example.com to register (first-time users).
- Before you submit your Letter of Intent and application, download and read the CDP Guidelines and Instructions specific for your category. Do not use an old version.
- LLS staff will determine eligibility on a rolling basis using the criteria set forth by our independent oversight committees and described in the sections detailed in the guidelines and instructions.
- If you have any technical difficulties with the research portal powered by Fluxx, please contact us via email at firstname.lastname@example.org.
|Eligibility Phase: open||July 2017|
|Eligibility determination by LLS staff||July 18 - September 8, 2017|
|Eligibility Phase: close||September 1, 2017||3:00 PM ET|
|Notification of eligibility||By September 8, 2017||3:00 PM ET|
|Abstract Phase: open||After eligibility is approved|
|Abstract Phase: close||September 15, 2017||3:00 PM ET|
|Full Application Phase: open||After Abstract submission|
|Reference letters due||October 3, 2017||3:00 PM ET|
|Full Application Phase: close||October 3, 2017||3:00 PM ET|
|Panel Review Meeting||January 2018|
|Award Notification||Late February 2018|
|Final version of Lay Abstract due||May 1, 2018|
|LLS’s receipt of signed contract||May 1, 2018|
|Award Start Date||July 1, 2018|
Note: the Special Fellow in Clinical Research sub-program will not run this year.
Frequently Asked Questions
|Scholar||Scholar in Clinical Research||Special Fellow (2 year Award)||Special Fellow (3 year Award)||Fellow|
|Degree*||MD, PhD, DVM, or equivalent||MD, PhD, DVM, or equivalent||MD, PhD, DVM, or equivalent||MD, PhD, DVM, or equivalent||MD, PhD, DVM, or equivalent|
|Oral thesis defense date**||n/a||n/a||On or after July 1, 2013||On or after July 1, 2014||On or afterJanuary 1, 2016|
|Must hold independent faculty position***||Yes||Yes||No||No||No|
|Start date of independent position***||On or after January 1, 2010||On or after January 1, 2008||n/a||n/a||n/a|
|Applicant must have R01-level funding****||Yes||No*****||No||No||No|
|Sponsor must have R01-level funding****||n/a||n/a||Yes||Yes||Yes|
*For Fellows, the degree must be conferred by the Award start date of July 1, 2018
**More details are contained in the Guidelines & Instructions
***Mentored faculty positions (e.g. Instructor) do not count as independent
****Substantial, peer-reviewed funding that extends beyond July 1, 2018; must be the principal investigator on this funding
*****Funding may come from any source; see the Guidelines & Instructions for more details
Award: $110,000 per year for five years
Requirements: You must be a highly qualified investigator who's shown a capacity for independent, sustained original investigation in the field of hematologic malignancies. You should hold an independent faculty-level or equivalent position and have obtained substantial support for your research from a national agency.
Scholar in Clinical Research
New this year: Eligibility is expanded to include any permanent, independent clinical faculty who are not on a laboratory-based, tenure-track career path. The research support requirement is expanded to include funding from any source that adequately supports the research. Protected time for research is now defined to be in the range of 20-40%. The award amount is increased to $125,000/year. Some of the award may be used for salaries of other personnel who are directly connected with the clinical research activities of the applicant.
**Please refer to the guidelines and instructions for more details regarding changes to the eligibility criteria if applying to this sub-program.
Award: $125,000 per year for five years
Requirements: You must be a highly qualified investigator who holds an independent faculty-level appointment and is conducting original, independent applied research, often involving early-stage clinical trials that will advance the prevention, diagnosis or treatment of hematologic malignancies. You're expected to have concomitant support for your research from another source or agency.
Award: $67,000 per year for two or three years
Requirements: You must be a qualified investigator who's completed a minimum of two years of postdoctoral research training and is continuing a mentored research position. This award is meant to permit you to begin to transition to an independent research program.
Award: $60,000 per year for three years
Requirements: You must be a promising investigator with less than two years of postdoctoral research training. This award encourages you to embark on an academic career involving clinical or fundamental research in hematologic malignancies under a research sponsor's direction. Applicant's from a variety of disciplines are encouraged to apply, but the proposal must be directly relevant to hematological malignancies and/or relevant pre-malignant conditions.
Need More Information?
Senior Director of Research Administration
The Leukemia & Lymphoma Society, Inc.
3 International Drive, Suite 200
Rye Brook, NY 10573